- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
Today, in a joint effort between Congressional Representatives and Americans for Safe Access, several members of Congress sent a letter to President Obama expressing "concern with the recent activity by the Department of Justice against legitimate medical cannabis dispensaries in California that are operating legally under state law." The letter, headlined by Representatives Sam Farr (D-CA) and Dana Rohrabacher (R-CA) and signed by Representatives Mike Thompson (D-CA), Jared Polis (D-CO), Pete Stark (D-CA), Steve Cohen (D-TN), Barbara Lee (D-CA), Lynn Woolsey (D-CA), and Bob Filner (D-CA), noted that California was only the latest state hit in the federal government's campaign against medical marijuana.
This year alone has seen aggressive SWAT-style federal raids in at least seven medical marijuana states, as well as threats of criminal prosecution by U.S. attorneys against local and state public officials. It is our strong position that local and state governments must be allowed to develop, implement and enforce their own public health laws with regard to medical cannabis.
The members of Congress further stated that:
[I]t is more urgent now than ever to reschedule marijuana as a legitimate controlled substance for medicinal purposes.
Specifically, they requested that the Obama administration either reschedule cannabis as a Schedule II or Schedule III drug or that they publicly support the adoption of legislation that would remove cannabis from its current place in Schedule I. The letter comes on the heels of the Department of Justice's most recent attempt to circumvent California's 15 year old medical cannabis law.
In the beginning of October, California's four U.S. attorneys sent letters to at least 16 landlords and property owners who rent buildings or own land where dispensaries provide safe access to medical cannabis, notifying them that they were violating federal drug law. The letters warned that the dispensaries must shut down within 45 days or the landlords and property owners will face criminal charges and confiscation of their property - both real and personal - even if they are operating legally under the state's medical cannabis law.
This latest instance of federal interference is in stark contrast to the spirit if not the precise letter of the Obama Administration's policy on medical cannabis and though the DOJ is now claiming that President Obama had no prior knowledge of these latest enforcement tactics, the signers of the Farr-Rohrabacher letter urge the President to show respect for patients and their providers by changing federal policy and providing them with safe access to their medicine rather than pushing them back into the illicit market. Whether or not their pleas fall on deaf ears remains to be seen.